The Bioassay Lab, THSTI, conducted a hands-on training session on the 50% Plaque Reduction Neutralization Test (PRNT₅₀) assay for the Vaccine Division officials of Central Drugs Standard Control Organization (CDSCO) on February 14, 2026. This intensive session provided technical expertise towards strengthening regulatory capacity, and enhancing collaboration between research laboratories and national regulatory authorities.